Abiopharma

🔍 Vo Thomas T. (Director)

Company: Nutex Health Inc. (NUTX)

Report Date: 2026-03-09

Detailed Transactions and Holdings:

• Acquired 8,334 shares of Common Stock (Direct)
  Date: 2026-03-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,846,213.00 | transaction_form_type: 4 | Footnotes: F1, F1, F4
• Sold 3,017 shares of Common Stock at $86.2224 per share (Direct)
  Date: 2026-03-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,843,196.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Acquired 4,841 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-10 | Code: M | Expires: 2029-03-01 | Exercise: 2027-03-01 | equity_swap_involved: 0 | shares_owned_after: 19,524.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F3

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: Of the 8,334 shares issued subsequent to vesting, 3,017 shares were sold to cover tax withholding obligations.
• F3: On March 11, 2026, the Reporting Person was granted 4,841 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.
• F4: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,840,898 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.